HEADER TRANSCRIPTION ACTIVATOR 18-FEB-10 3LUR TITLE CRYSTAL STRUCTURE OF PUTATIVE BACTERIAL TRANSCRIPTION REGULATION TITLE 2 PROTEIN (NP_372959.1) FROM STAPHYLOCOCCUS AUREUS MU50 AT 1.81 A TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE BACTERIAL TRANSCRIPTION REGULATION PROTEIN; COMPND 3 CHAIN: A, B, C; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 158878; SOURCE 4 STRAIN: MU50 / ATCC 700699; SOURCE 5 GENE: SAV2435; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, PSI-2, BACTERIAL TRANSCRIPTION KEYWDS 3 ACTIVATOR, EFFECTOR BINDING DOMAIN, TRANSCRIPTION ACTIVATOR EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 30-OCT-24 3LUR 1 REMARK REVDAT 5 01-FEB-23 3LUR 1 REMARK SEQADV REVDAT 4 17-JUL-19 3LUR 1 REMARK LINK REVDAT 3 08-NOV-17 3LUR 1 REMARK REVDAT 2 13-JUL-11 3LUR 1 VERSN REVDAT 1 09-MAR-10 3LUR 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE BACTERIAL TRANSCRIPTION JRNL TITL 2 REGULATION PROTEIN (NP_372959.1) FROM STAPHYLOCOCCUS AUREUS JRNL TITL 3 MU50 AT 1.81 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.19 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 39762 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.81 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.86 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2731 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.69 REMARK 3 BIN R VALUE (WORKING SET) : 0.2290 REMARK 3 BIN FREE R VALUE SET COUNT : 130 REMARK 3 BIN FREE R VALUE : 0.2480 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3668 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 322 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 18.43 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.45000 REMARK 3 B22 (A**2) : 0.07000 REMARK 3 B33 (A**2) : 0.47000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.69000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.148 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.135 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.091 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.474 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4045 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2698 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5509 ; 1.410 ; 1.957 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6693 ; 0.759 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 541 ; 4.320 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 190 ;27.865 ;26.263 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 721 ;10.938 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;18.348 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 604 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4565 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 754 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2446 ; 0.574 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1005 ; 0.149 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3971 ; 1.050 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1599 ; 1.700 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1501 ; 2.816 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B C REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 6 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 4 A 16 4 REMARK 3 1 B 4 B 16 4 REMARK 3 1 C 4 C 16 4 REMARK 3 2 A 51 A 63 4 REMARK 3 2 B 51 B 63 4 REMARK 3 2 C 51 C 63 4 REMARK 3 3 A 72 A 77 4 REMARK 3 3 B 72 B 77 4 REMARK 3 3 C 72 C 77 4 REMARK 3 4 A 87 A 100 4 REMARK 3 4 B 87 B 100 4 REMARK 3 4 C 87 C 100 4 REMARK 3 5 A 131 A 138 4 REMARK 3 5 B 131 B 138 4 REMARK 3 5 C 131 C 138 4 REMARK 3 6 A 148 A 156 4 REMARK 3 6 B 148 B 156 4 REMARK 3 6 C 148 C 156 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 711 ; 0.360 ; 0.500 REMARK 3 MEDIUM POSITIONAL 1 B (A): 711 ; 0.310 ; 0.500 REMARK 3 MEDIUM POSITIONAL 1 C (A): 711 ; 0.360 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 711 ; 1.110 ; 2.000 REMARK 3 MEDIUM THERMAL 1 B (A**2): 711 ; 0.780 ; 2.000 REMARK 3 MEDIUM THERMAL 1 C (A**2): 711 ; 0.950 ; 2.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 157 REMARK 3 ORIGIN FOR THE GROUP (A): 22.4870 21.5330 6.1190 REMARK 3 T TENSOR REMARK 3 T11: 0.0323 T22: 0.0183 REMARK 3 T33: 0.0433 T12: 0.0013 REMARK 3 T13: 0.0107 T23: -0.0048 REMARK 3 L TENSOR REMARK 3 L11: 2.5465 L22: 0.9470 REMARK 3 L33: 1.5734 L12: -0.2281 REMARK 3 L13: 0.5603 L23: -0.2661 REMARK 3 S TENSOR REMARK 3 S11: -0.0242 S12: -0.2030 S13: 0.0135 REMARK 3 S21: 0.0894 S22: 0.0220 S23: 0.0305 REMARK 3 S31: -0.0200 S32: -0.0174 S33: 0.0022 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 0 B 157 REMARK 3 ORIGIN FOR THE GROUP (A): 27.4840 26.1390 39.8670 REMARK 3 T TENSOR REMARK 3 T11: 0.0340 T22: 0.0443 REMARK 3 T33: 0.0477 T12: -0.0042 REMARK 3 T13: -0.0058 T23: -0.0067 REMARK 3 L TENSOR REMARK 3 L11: 1.6725 L22: 0.7409 REMARK 3 L33: 0.9942 L12: -0.0983 REMARK 3 L13: -0.2200 L23: -0.2907 REMARK 3 S TENSOR REMARK 3 S11: 0.0184 S12: 0.0704 S13: -0.0109 REMARK 3 S21: 0.0292 S22: -0.0330 S23: -0.0518 REMARK 3 S31: -0.0593 S32: 0.0625 S33: 0.0147 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 0 C 157 REMARK 3 ORIGIN FOR THE GROUP (A): 17.5320 54.7610 32.0710 REMARK 3 T TENSOR REMARK 3 T11: 0.0490 T22: 0.0561 REMARK 3 T33: 0.0913 T12: -0.0017 REMARK 3 T13: 0.0108 T23: 0.0108 REMARK 3 L TENSOR REMARK 3 L11: 1.0838 L22: 1.5917 REMARK 3 L33: 3.0680 L12: -0.0314 REMARK 3 L13: 0.0239 L23: -0.3212 REMARK 3 S TENSOR REMARK 3 S11: -0.0285 S12: 0.0338 S13: 0.1079 REMARK 3 S21: -0.1246 S22: -0.0675 S23: -0.0274 REMARK 3 S31: 0.0048 S32: 0.1025 S33: 0.0960 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. POLYETHYLENE GLYCOL (PG4 AND PEG) FROM THE REMARK 3 CRYSTALLIZATION WERE MODELED INTO THE STRUCTURE. 4. ETHYLENE REMARK 3 GLYCOL (EDO) USED AS A CRYOPROTECTANT WAS MODELED INTO THE REMARK 3 STRUCTURE. 5.ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY REMARK 4 REMARK 4 3LUR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1000057755. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97932,0.97949 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39778 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.810 REMARK 200 RESOLUTION RANGE LOW (A) : 29.192 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.81 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.42100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2000M NH4F, 20.0000% PEG-3350, NO REMARK 280 BUFFER PH 6.2, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.24100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP C 78 REMARK 465 ASN C 79 REMARK 465 SER C 80 REMARK 465 ALA C 81 REMARK 465 ASP C 82 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 21 CG CD OE1 OE2 REMARK 470 ARG A 24 NH1 NH2 REMARK 470 ASP A 66 CG OD1 OD2 REMARK 470 ILE A 83 CG1 CG2 CD1 REMARK 470 LYS A 85 CD CE NZ REMARK 470 LYS A 107 CE NZ REMARK 470 GLU A 114 CD OE1 OE2 REMARK 470 GLU B 2 CG CD OE1 OE2 REMARK 470 GLN B 27 CD OE1 NE2 REMARK 470 GLU B 145 CD OE1 OE2 REMARK 470 LYS C 107 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP C 141 O HOH C 317 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MSE A 1 33.38 -99.34 REMARK 500 SER B 130 55.85 -93.11 REMARK 500 MSE C 1 146.02 -173.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 158 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 159 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 160 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 161 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 162 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 158 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 159 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 160 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 161 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO C 158 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO C 159 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO C 160 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 399559 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3LUR A 1 157 UNP Q99RJ7 Q99RJ7_STAAM 1 157 DBREF 3LUR B 1 157 UNP Q99RJ7 Q99RJ7_STAAM 1 157 DBREF 3LUR C 1 157 UNP Q99RJ7 Q99RJ7_STAAM 1 157 SEQADV 3LUR GLY A 0 UNP Q99RJ7 EXPRESSION TAG SEQADV 3LUR GLY B 0 UNP Q99RJ7 EXPRESSION TAG SEQADV 3LUR GLY C 0 UNP Q99RJ7 EXPRESSION TAG SEQRES 1 A 158 GLY MSE GLU TYR GLN LEU GLN GLN LEU ALA SER LEU THR SEQRES 2 A 158 LEU VAL GLY ILE LYS GLU THR TYR GLU ASN GLY ARG GLN SEQRES 3 A 158 ALA GLN GLN HIS ILE ALA GLY PHE TRP GLN ARG CYS TYR SEQRES 4 A 158 GLN GLU GLY VAL ILE ALA ASP LEU GLN LEU LYS ASN ASN SEQRES 5 A 158 GLY ASP LEU ALA GLY ILE LEU GLY LEU CYS ILE PRO GLU SEQRES 6 A 158 LEU ASP GLY LYS MSE SER TYR MSE ILE ALA VAL THR GLY SEQRES 7 A 158 ASP ASN SER ALA ASP ILE ALA LYS TYR ASP VAL ILE THR SEQRES 8 A 158 LEU ALA SER SER LYS TYR MSE VAL PHE GLU ALA GLN GLY SEQRES 9 A 158 ALA VAL PRO LYS ALA VAL GLN GLN LYS MSE GLU GLU VAL SEQRES 10 A 158 HIS HIS TYR ILE HIS GLN TYR GLN ALA ASN THR VAL LYS SEQRES 11 A 158 SER ALA PRO PHE PHE GLU LEU TYR GLN ASP GLY ASP THR SEQRES 12 A 158 THR SER GLU LYS TYR ILE THR GLU ILE TRP MSE PRO VAL SEQRES 13 A 158 LYS GLY SEQRES 1 B 158 GLY MSE GLU TYR GLN LEU GLN GLN LEU ALA SER LEU THR SEQRES 2 B 158 LEU VAL GLY ILE LYS GLU THR TYR GLU ASN GLY ARG GLN SEQRES 3 B 158 ALA GLN GLN HIS ILE ALA GLY PHE TRP GLN ARG CYS TYR SEQRES 4 B 158 GLN GLU GLY VAL ILE ALA ASP LEU GLN LEU LYS ASN ASN SEQRES 5 B 158 GLY ASP LEU ALA GLY ILE LEU GLY LEU CYS ILE PRO GLU SEQRES 6 B 158 LEU ASP GLY LYS MSE SER TYR MSE ILE ALA VAL THR GLY SEQRES 7 B 158 ASP ASN SER ALA ASP ILE ALA LYS TYR ASP VAL ILE THR SEQRES 8 B 158 LEU ALA SER SER LYS TYR MSE VAL PHE GLU ALA GLN GLY SEQRES 9 B 158 ALA VAL PRO LYS ALA VAL GLN GLN LYS MSE GLU GLU VAL SEQRES 10 B 158 HIS HIS TYR ILE HIS GLN TYR GLN ALA ASN THR VAL LYS SEQRES 11 B 158 SER ALA PRO PHE PHE GLU LEU TYR GLN ASP GLY ASP THR SEQRES 12 B 158 THR SER GLU LYS TYR ILE THR GLU ILE TRP MSE PRO VAL SEQRES 13 B 158 LYS GLY SEQRES 1 C 158 GLY MSE GLU TYR GLN LEU GLN GLN LEU ALA SER LEU THR SEQRES 2 C 158 LEU VAL GLY ILE LYS GLU THR TYR GLU ASN GLY ARG GLN SEQRES 3 C 158 ALA GLN GLN HIS ILE ALA GLY PHE TRP GLN ARG CYS TYR SEQRES 4 C 158 GLN GLU GLY VAL ILE ALA ASP LEU GLN LEU LYS ASN ASN SEQRES 5 C 158 GLY ASP LEU ALA GLY ILE LEU GLY LEU CYS ILE PRO GLU SEQRES 6 C 158 LEU ASP GLY LYS MSE SER TYR MSE ILE ALA VAL THR GLY SEQRES 7 C 158 ASP ASN SER ALA ASP ILE ALA LYS TYR ASP VAL ILE THR SEQRES 8 C 158 LEU ALA SER SER LYS TYR MSE VAL PHE GLU ALA GLN GLY SEQRES 9 C 158 ALA VAL PRO LYS ALA VAL GLN GLN LYS MSE GLU GLU VAL SEQRES 10 C 158 HIS HIS TYR ILE HIS GLN TYR GLN ALA ASN THR VAL LYS SEQRES 11 C 158 SER ALA PRO PHE PHE GLU LEU TYR GLN ASP GLY ASP THR SEQRES 12 C 158 THR SER GLU LYS TYR ILE THR GLU ILE TRP MSE PRO VAL SEQRES 13 C 158 LYS GLY MODRES 3LUR MSE A 1 MET SELENOMETHIONINE MODRES 3LUR MSE A 69 MET SELENOMETHIONINE MODRES 3LUR MSE A 72 MET SELENOMETHIONINE MODRES 3LUR MSE A 97 MET SELENOMETHIONINE MODRES 3LUR MSE A 113 MET SELENOMETHIONINE MODRES 3LUR MSE A 153 MET SELENOMETHIONINE MODRES 3LUR MSE B 1 MET SELENOMETHIONINE MODRES 3LUR MSE B 69 MET SELENOMETHIONINE MODRES 3LUR MSE B 72 MET SELENOMETHIONINE MODRES 3LUR MSE B 97 MET SELENOMETHIONINE MODRES 3LUR MSE B 113 MET SELENOMETHIONINE MODRES 3LUR MSE B 153 MET SELENOMETHIONINE MODRES 3LUR MSE C 1 MET SELENOMETHIONINE MODRES 3LUR MSE C 69 MET SELENOMETHIONINE MODRES 3LUR MSE C 72 MET SELENOMETHIONINE MODRES 3LUR MSE C 97 MET SELENOMETHIONINE MODRES 3LUR MSE C 113 MET SELENOMETHIONINE MODRES 3LUR MSE C 153 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 69 8 HET MSE A 72 8 HET MSE A 97 8 HET MSE A 113 8 HET MSE A 153 13 HET MSE B 1 8 HET MSE B 69 8 HET MSE B 72 8 HET MSE B 97 8 HET MSE B 113 8 HET MSE B 153 8 HET MSE C 1 8 HET MSE C 69 8 HET MSE C 72 8 HET MSE C 97 8 HET MSE C 113 8 HET MSE C 153 8 HET PG4 A 158 13 HET EDO A 159 4 HET EDO A 160 4 HET EDO A 161 4 HET EDO A 162 4 HET EDO A 163 4 HET PEG B 158 7 HET EDO B 159 4 HET EDO B 160 4 HET EDO B 161 4 HET EDO C 158 4 HET EDO C 159 4 HET EDO C 160 4 HETNAM MSE SELENOMETHIONINE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM EDO 1,2-ETHANEDIOL HETNAM PEG DI(HYDROXYETHYL)ETHER HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 18(C5 H11 N O2 SE) FORMUL 4 PG4 C8 H18 O5 FORMUL 5 EDO 11(C2 H6 O2) FORMUL 10 PEG C4 H10 O3 FORMUL 17 HOH *322(H2 O) HELIX 1 1 ASN A 22 GLU A 40 1 19 HELIX 2 2 GLY A 41 ASN A 50 1 10 HELIX 3 3 ALA A 81 TYR A 86 5 6 HELIX 4 4 PRO A 106 GLN A 124 1 19 HELIX 5 5 ASN B 22 GLU B 40 1 19 HELIX 6 6 GLY B 41 ASN B 50 1 10 HELIX 7 7 PRO B 106 GLN B 124 1 19 HELIX 8 8 ASN C 22 GLU C 40 1 19 HELIX 9 9 GLY C 41 ASN C 50 1 10 HELIX 10 10 LEU C 65 GLY C 67 5 3 HELIX 11 11 PRO C 106 GLN C 124 1 19 HELIX 12 12 ALA C 125 VAL C 128 5 4 SHEET 1 A 8 GLN A 4 LEU A 8 0 SHEET 2 A 8 SER A 94 GLN A 102 -1 O TYR A 96 N GLN A 6 SHEET 3 A 8 ILE A 148 VAL A 155 -1 O THR A 149 N ALA A 101 SHEET 4 A 8 PHE A 133 TYR A 137 -1 N PHE A 134 O TRP A 152 SHEET 5 A 8 ILE A 57 PRO A 63 -1 N CYS A 61 O PHE A 133 SHEET 6 A 8 MSE A 69 THR A 76 -1 O MSE A 72 N LEU A 60 SHEET 7 A 8 LEU A 11 TYR A 20 -1 N TYR A 20 O MSE A 69 SHEET 8 A 8 ASP A 87 LEU A 91 -1 O ILE A 89 N LEU A 13 SHEET 1 B 8 GLN B 4 LEU B 8 0 SHEET 2 B 8 SER B 94 GLN B 102 -1 O VAL B 98 N GLN B 4 SHEET 3 B 8 ILE B 148 VAL B 155 -1 O THR B 149 N ALA B 101 SHEET 4 B 8 PHE B 133 TYR B 137 -1 N PHE B 134 O TRP B 152 SHEET 5 B 8 ILE B 57 PRO B 63 -1 N CYS B 61 O PHE B 133 SHEET 6 B 8 MSE B 69 THR B 76 -1 O ALA B 74 N LEU B 58 SHEET 7 B 8 LEU B 11 TYR B 20 -1 N VAL B 14 O VAL B 75 SHEET 8 B 8 ASP B 87 LEU B 91 -1 O ASP B 87 N GLY B 15 SHEET 1 C 8 GLN C 4 LEU C 8 0 SHEET 2 C 8 SER C 94 GLN C 102 -1 O SER C 94 N LEU C 8 SHEET 3 C 8 ILE C 148 VAL C 155 -1 O ILE C 151 N PHE C 99 SHEET 4 C 8 PHE C 133 TYR C 137 -1 N PHE C 134 O TRP C 152 SHEET 5 C 8 ILE C 57 PRO C 63 -1 N ILE C 57 O TYR C 137 SHEET 6 C 8 MSE C 69 THR C 76 -1 O ALA C 74 N LEU C 58 SHEET 7 C 8 LEU C 11 TYR C 20 -1 N TYR C 20 O MSE C 69 SHEET 8 C 8 ASP C 87 LEU C 91 -1 O LEU C 91 N LEU C 11 LINK C GLY A 0 N MSE A 1 1555 1555 1.33 LINK C MSE A 1 N GLU A 2 1555 1555 1.33 LINK C LYS A 68 N MSE A 69 1555 1555 1.33 LINK C MSE A 69 N SER A 70 1555 1555 1.33 LINK C TYR A 71 N MSE A 72 1555 1555 1.31 LINK C MSE A 72 N ILE A 73 1555 1555 1.32 LINK C TYR A 96 N MSE A 97 1555 1555 1.34 LINK C MSE A 97 N VAL A 98 1555 1555 1.32 LINK C LYS A 112 N MSE A 113 1555 1555 1.33 LINK C MSE A 113 N GLU A 114 1555 1555 1.32 LINK C TRP A 152 N MSE A 153 1555 1555 1.33 LINK C MSE A 153 N PRO A 154 1555 1555 1.34 LINK C GLY B 0 N MSE B 1 1555 1555 1.33 LINK C MSE B 1 N GLU B 2 1555 1555 1.32 LINK C LYS B 68 N MSE B 69 1555 1555 1.33 LINK C MSE B 69 N SER B 70 1555 1555 1.31 LINK C TYR B 71 N MSE B 72 1555 1555 1.32 LINK C MSE B 72 N ILE B 73 1555 1555 1.31 LINK C TYR B 96 N MSE B 97 1555 1555 1.34 LINK C MSE B 97 N VAL B 98 1555 1555 1.32 LINK C LYS B 112 N MSE B 113 1555 1555 1.34 LINK C MSE B 113 N GLU B 114 1555 1555 1.33 LINK C TRP B 152 N MSE B 153 1555 1555 1.33 LINK C MSE B 153 N PRO B 154 1555 1555 1.35 LINK C GLY C 0 N MSE C 1 1555 1555 1.33 LINK C MSE C 1 N GLU C 2 1555 1555 1.33 LINK C LYS C 68 N MSE C 69 1555 1555 1.32 LINK C MSE C 69 N SER C 70 1555 1555 1.33 LINK C TYR C 71 N MSE C 72 1555 1555 1.33 LINK C MSE C 72 N ILE C 73 1555 1555 1.33 LINK C TYR C 96 N MSE C 97 1555 1555 1.32 LINK C MSE C 97 N VAL C 98 1555 1555 1.33 LINK C LYS C 112 N MSE C 113 1555 1555 1.33 LINK C MSE C 113 N GLU C 114 1555 1555 1.32 LINK C TRP C 152 N MSE C 153 1555 1555 1.33 LINK C MSE C 153 N PRO C 154 1555 1555 1.34 CISPEP 1 VAL A 105 PRO A 106 0 5.62 CISPEP 2 VAL B 105 PRO B 106 0 2.92 CISPEP 3 VAL C 105 PRO C 106 0 1.58 SITE 1 AC1 9 TRP A 34 TYR A 38 SER A 130 TYR A 137 SITE 2 AC1 9 GLN A 138 ASP A 139 GLY A 140 THR A 142 SITE 3 AC1 9 HOH A 211 SITE 1 AC2 6 GLN A 138 ASP A 139 LYS A 156 EDO A 162 SITE 2 AC2 6 HOH A 187 HOH A 197 SITE 1 AC3 4 ARG A 36 GLU A 40 HIS B 29 HOH B 187 SITE 1 AC4 2 HIS A 117 ILE A 120 SITE 1 AC5 6 GLN A 47 GLY A 56 ILE A 57 TYR A 137 SITE 2 AC5 6 ASP A 139 EDO A 159 SITE 1 AC6 8 ALA A 55 LEU A 136 GLN A 138 GLU A 150 SITE 2 AC6 8 HOH A 187 HOH A 194 HOH A 220 HOH A 232 SITE 1 AC7 3 TRP B 34 VAL B 105 HOH B 230 SITE 1 AC8 2 ARG B 36 GLU B 40 SITE 1 AC9 3 HIS B 117 ILE B 120 HOH B 238 SITE 1 BC1 2 GLN B 124 THR B 127 SITE 1 BC2 5 ILE C 16 GLU C 18 ARG C 36 CYS C 37 SITE 2 BC2 5 GLU C 40 SITE 1 BC3 4 MSE C 1 GLU C 2 TYR C 3 HOH C 333 SITE 1 BC4 2 GLN C 6 GLN C 7 CRYST1 34.179 62.482 105.075 90.00 93.33 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029258 0.000000 0.001703 0.00000 SCALE2 0.000000 0.016005 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009533 0.00000